ArticleActa pharmacologica Sinica2022

Establishment of an in vitro safety assessment model for lipid-lowering drugs using same-origin human pluripotent stem cell-derived cardiomyocytes and endothelial cells.

Xuan Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.